Area of research
Genetics · Epidemiology
Research interest
Research interests include Inflammatory Bowel Disease, Microscopic Colitis, Biosimilars and Bioanalytical Methods, and Rheumatoid Arthritis Research and Therapies.
Meta‐analysis: Persistence of advanced therapies in the treatment of inflammatory bowel disease
Vedolizumab has longer persistence than infliximab as a first-line biological agent but not as a second-line biological agent in moderate-to-severe ulcerative colitis: real-world registry data from the Persistence Australian National IBD Cohort (PANIC) study
Superior treatment persistence with ustekinumab in Crohn’s disease and vedolizumab in ulcerative colitis compared with anti‐TNF biological agents: real‐world registry data from the Persistence Australian National IBD Cohort (PANIC) study
Systematic review with meta‐analysis: breastfeeding and the risk of Crohn's disease and ulcerative colitis
Environmental risk factors in inflammatory bowel disease: a population-based case-control study in Asia-Pacific